Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Contributed by: Business Wire

Logo

Tags

Health

Consumer

Women

Other Health

Clinical Trials

Pharmaceutical

Biotechnology

Menopause-related Skin Changes

More Like This

Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines

PR Newswire associated0

WGSN trends forecasters have 'Hormonal Skincare' predicted as a big beauty trend for 2024

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

AMWC 2024: Galderma to Share New Data From Its Leading Injectable Aesthetic Portfolio